Urothelial carcinoma affects the urinary bladder, renal pelvis, and ureter. Risk factors include smoking, exposure to chemicals like arsenic or cyclophosphamide, and schistosomiasis infection. It is caused by genetic alterations and environmental exposures. Pathologically, it presents as increased cell layers in the urothelium and can be low or high grade, with high grade tumors more likely to invade surrounding tissues. Clinical features may include hematuria, flank pain, and hydronephrosis. Prognosis depends on grade, size, and extent of disease.
Urothelial carcinoma affects the urinary bladder, renal pelvis, and ureter. Risk factors include smoking, exposure to chemicals like arsenic or cyclophosphamide, and schistosomiasis infection. It is caused by genetic alterations and environmental exposures. Pathologically, it presents as increased cell layers in the urothelium and can be low or high grade, with high grade tumors more likely to invade surrounding tissues. Clinical features may include hematuria, flank pain, and hydronephrosis. Prognosis depends on grade, size, and extent of disease.
Urothelial carcinoma affects the urinary bladder, renal pelvis, and ureter. Risk factors include smoking, exposure to chemicals like arsenic or cyclophosphamide, and schistosomiasis infection. It is caused by genetic alterations and environmental exposures. Pathologically, it presents as increased cell layers in the urothelium and can be low or high grade, with high grade tumors more likely to invade surrounding tissues. Clinical features may include hematuria, flank pain, and hydronephrosis. Prognosis depends on grade, size, and extent of disease.
· Affects the urinary bladder, renal pelvis, and ureter
· Sites: Lateral or posterior walls at the base of the urinary bladder · Causes: (Pee SAC) ® Phenacetin ® Smoking - 4x greater risk ® Workers in Aniline dye, rubber, paint, and leather industries ® Cyclophosphamide, arsenic exposure ® Nitrosamines ® Schistosoma haematobium infection (30%) · Pathogenesis ® Genetic factors: p53 and RB supressor genes and HRAS proto-oncogene, alterations in EGFR ® Environmental factors ® Gross findings ▪ Tumor in the pelvis o A small non-invasive papillary urothelial carcinoma involving the renal pelvis o Patient will present with gross hematuria o Smooth, pink-gray urothelial lining in the uninvolved areas
Figure X. H&E slide of a NORMAL urothelium of the urinary bladder,
characterized with 6-7 layers of cells, with intact basement membrane, and good basal nuclei polarity.
Table __. Classification of bladder tumors.
From the recording: No need to memorize the table, just be familiar that a Figure X. Gross specimen of papillary urothelial carcinoma. A papillary tumor papilloma is benign, a PUNLMP has borderline potential, and that both low grade extended at the calyces with cauliflower-like pattern, showing multifocal, and high grade papillary carcinomas are malignant exophytic, pink-tan neoplasm arising in the calyces and pelvis.
· WHO Classification of Non-invasive and Invasive Urothelial
® Histopathology Neoplasia ▪ Both low grade and high grade wil present with increased ® Non-invasive Urothelial Neoplasia layers in urothelium (> 7 layers) ▪ Hyperplasia (flat and paillary ▪ Low Grade- usually papillary and typically not invasive ▪ High Grade- papillary or flat and usually invasive ▪ Reactive atypia ▪ Atypia of unknown significance ▪ Urothelial dysplasia (low-grade intraurothelial neoplasia) ▪ Urothelial carcinoma in situ (high-grade intraurothelial neoplasia) ▪ Urothelial papilloma ▪ Urothelial papilloma, inverted type ▪ Papillary urothelial neoplasm of low malignant potential ▪ Non-invasive low-grade papillary urothelial carcinoma ▪ Non-invasive high-grade papillary urothelial carcinoma ® Invasive Urothelial Neoplasia ▪ Lamina propria invasion Figure X. Left: Low grade papillary urothelial carcinoma characterized with mild ▪ Muscularis propria (detrusor muscle) invasion pleiomorphism, increased mitotic activity, and loss of nuclei polarity Right: High grade papillary urothelial carcinoma characterized with more atypical cells · Prognosis: ® Five year survival rate for all stages combined is 80% ® Potential for recurrence is greatest with high grade, multifocal disease and increasing size of the tumor ® Poor prognosis ▪ Infiltration of the wall of the pelvis and calyces ▪ Easily infiltrates the fatty tissue · Clinical Features ® Hematuria- via fragmentation ® Palpable hydronephrosis and flank pain due to blockage of urinary outflow ® In 50% of cases, there is a preexisting or concomitant bladder urothelial tumor · Tumors that can arise ® Transitional epithelial carcinoma ® Atypia, loss of polarity ® Squamous Cell Carcinoma ® Risk factors: renal stones and chronic infection